Our findings suggest that DNA hypomethylation at lipogenic genes in NAFLD patients may, thus, be in part due to decreased DNMT3A occupancy at lipogenic genes as a result of a defective FGF15/19-SHP axis, which contributes to increased gene expression. The gene discussed is NR0B2; the disease is metabolic dysfunction-associated steatotic liver disease.